Trial NCT04335786

View at ClinicalTrials.gov 
Org. Study IDs: NL73547.091.20
Secondary IDs: 2020-001320-34

Last trial update was posted on 2021-09-24

MeSH Interventions

Valsartan

MeSH Conditions

Acute Lung Injury COVID-19 Respiratory Distress Syndrome Respiratory Distress Syndrome, Newborn Severe Acute Respiratory Syndrome Syndrome

Other Conditions

Acute Respiratory Distress Syndrome COVID SARS-CoV-2

Stopping Reasons

Enrollment was stopped to facilitate successful enrollment for the ACE2RAS-domain of the REMAP-CAP trial.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID